Forte Biosciences, Inc. Common Stock FBRX
$76.83
+0.29%
at last close
Market Cap$1.57 billion
P/E Ratio—
Div Yield—
Volume1.73M
52-Week Range
$9.10$77.20
Key Stats
- Today's Range
- $76.72 – $76.83
- 50-Day Range
- $15.51 – $77.20
- 52-Week Range
- $9.10 – $77.20
- Volume
- 1.73 million shs
- Average Volume
- 1.88 million shs
- Market Cap
- $1.57 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.37%
- Days to Cover
- 1.16
About Forte Biosciences, Inc. Common Stock
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Related Stocks
Compare head-to-head: FBRX vs LLY·FBRX vs JNJ·FBRX vs ABBV·FBRX vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.